Synovial fluid oxidative stress index as a biomarker for arthritis severity in thoroughbred racehorses.

Overview

• This study investigates whether the oxidative stress index (OSI) in synovial fluid can serve as a biomarker for determining the severity of arthritis in Thoroughbred racehorses.
• The goal is to improve assessment of disease status to guide treatment duration and decisions about returning to training.

Background and Importance

• Arthritis is a common cause of lameness in racehorses, which can hinder performance and result in repeated bouts despite treatment.
• Current challenges include difficulty in accurately assessing the disease state and deciding when it is safe to end treatment or resume training.
• Radiographic evidence of joint disease is helpful but may not always be present or correlate clearly with clinical symptoms.

Study Design

• This is a retrospective observational study using synovial fluid samples collected during routine clinical practice.
• A total of 72 Thoroughbred racehorses from Japan, aged approximately 3.4 years, participated.
• Horses were divided into two groups: 52 horses diagnosed with arthritis and 20 control horses without clinical or radiographic signs of carpal joint disease.
• The arthritis group was further categorized based on clinical stage into acute (AC), subacute (SA), or chronic (CH) phases.
• Additionally, arthritis cases were classified depending on the presence or absence of radiographic lesions.

Methods: Measurement of Oxidative Stress

• Two main oxidative stress markers were measured in the synovial fluid:
• Diacron-reactive oxygen metabolites (d-ROMs), which denote the level of oxidative compounds.
• Biological antioxidant potential (BAP), which represents the antioxidant capacity.
• The oxidative stress index (OSI) was calculated as: OSI = (d-ROMs / BAP) × 100, providing a ratio of oxidative burden relative to antioxidant defenses.

Key Findings

• The OSI was significantly higher in horses with acute arthritis compared to subacute, chronic arthritis, and control horses.
• In horses without radiographic lesions, the OSI was significantly lower than in those with lesions.
• This means oxidative stress levels in synovial fluid correlate with both the clinical stage and radiographic severity of arthritis.

Implications and Applications

• OSI in synovial fluid appears to be a quantitative biomarker reflecting the severity and activity of arthritis in racehorses.
• It has potential utility in clinical decision-making by:
• Helping to assess disease activity beyond clinical signs and radiographic findings.
• Informing veterinarians when it might be appropriate to cease treatment safely.
• Guiding timing for returning horses to training to prevent relapse of lameness.
• Particularly valuable for cases where radiographic lesions are absent but clinical assessment is ambiguous.

Limitations and Future Directions

• Retrospective nature means causality cannot be firmly established.
• Sample size, while reasonable, could be expanded for validation across broader populations.
• Further research may include prospective studies and exploration of whether interventions based on OSI readings improve long-term outcomes.

Summary

• This study identifies the synovial fluid oxidative stress index as a promising biomarker for arthritis severity in Thoroughbred racehorses.
• It enhances the ability to objectively evaluate disease status, aiding in tailored treatment and training decisions that could improve horse welfare and performance consistency.